Babar Z, Areesha Babar. FDA’s New Approval: Kisunla (Donanemab-Azbt) - A Major Breakthrough in Alzheimer’s Care. J Pak Med Assoc [Internet]. 2025 Jul. 1 [cited 2026 Apr. 18];75(07):1156-. Available from: https://jpma.org.pk/index.php/public_html/article/view/21951